For research use only. Not for therapeutic Use.
BN-82685 (Cat No.: I023582) is a small-molecule compound under investigation for its potential in cancer therapy, particularly as a modulator of specific protein interactions or signaling pathways involved in tumor growth and metastasis. It is designed to target key enzymes, receptors, or transcription factors that regulate cell proliferation and survival. BN-82685 has shown promise in preclinical studies for disrupting tumor cell growth, enhancing apoptosis, and potentially overcoming resistance to existing therapies. Further research is needed to assess its clinical efficacy and safety in cancer treatment.
CAS Number | 477603-18-2 |
Synonyms | 5-[2-(dimethylamino)ethylamino]-2-methyl-1,3-benzothiazole-4,7-dione |
Molecular Formula | C12H15N3O2S |
Purity | ≥95% |
InChI | InChI=1S/C12H15N3O2S/c1-7-14-10-11(17)8(13-4-5-15(2)3)6-9(16)12(10)18-7/h6,13H,4-5H2,1-3H3 |
InChIKey | MTUYOFGUEXWKLC-UHFFFAOYSA-N |
SMILES | CC1=NC2=C(S1)C(=O)C=C(C2=O)NCCN(C)C |
Reference | [1]. Marie-Christine Brezak, et al. IRC-083864, a novel bis quinone inhibitor of CDC25 phosphatases active against human cancer cells. Int J Cancer. 2009 Mar 15;124(6):1449-56. |